clinical studies

  1. Phase 2 study: Ibudilast's effects in progressive MS

    Phase 2 clinical trial shows that ibudilast is linked to a 48% slowing in the progression of brain atrophy compared to placebo for patients with progressive MS.

    red mri brain scan

    Read more »
  2. Going mobile - making healthcare more patient focussed

    Mobile has revolutionised everyday life and now big pharma is using smartphones and other mobile devices to improve research and development.

    Mobile phone with TheSocialMedwork service being used 

    Read more »
  3. Accessing edaravone in your country - the new FDA approved drug for ALS

    What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?

    edaravone FDA ALS

    Read more »
  4. Nivolumab Dominates the News

    Promising Results from Multiple Studies

    nivolumab news

    Read more »